156 - Combination Product Governance, Big Pharma to Medical Device Startups, Risk Management, Scale Up Challenges, Drug Delivery Innovations, and Home Administration with Laxman Halleppanavar

Let's Combinate · 2 Oct 2024 · 33m

What this episode covers

Laxman Halleppanavar, Head of Portfolio Strategy and Management at Credence MedSystems, discusses the complexities of combination products, contrasting his experience at large corporations like Pfizer and GE Healthcare with his current work in medical device startups. He highlights key industry trends including the shift toward home administration of drugs, sustainability goals, and the engineering challenges posed by high-viscosity, long-acting drugs and large injection volumes. Halleppanavar also explains the significant differences in risk management and regulatory scrutiny between medical devices and pharmaceuticals, noting the increased complexity when drugs are involved in combination products.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 42m

    #323 The Combination Products Handbook

    Susan Neadle, principal consultant and president of Combination Products Consulting Services, discusses her peer-reviewed book, The Combination Products Handbook: A Practical Guide, published by CRC Press. Neadle explains how she collaborated with FDA officials, including John Barwiener, and industry experts from companies like Johnson & Johnson, Novartis, and Pfizer to create a consolidated resource for the complex niche of combination products. The episode details the book's structure, covering regulatory strategies, CGMPs, risk management, and human factors, while highlighting the challenges of harmonizing terminology between pharmaceutical and medical device sectors. Neadle emphasizes the importance of holistic thinking and integrated development to ensure patient safety and regulatory compliance across global jurisdictions.

  • Global Medical Device Podcast · 38m

    #380: Navigating the Complex World of Combination Products with Subhi Saadeh

    Subhi Saadeh, host of the Combinate Podcast and expert in combination products, discusses the regulatory complexities of integrating drugs, devices, and biologics, including the differences between US FDA and EU regulatory pathways. He explains the definitions of single entity, co-packaged, and cross-labeled products, and addresses common misconceptions about the differences between drug and device quality systems. Saadeh also shares his journey of starting the podcast to maintain consistent learning and production, highlighting the importance of lifelong learning and leveraging coaching to balance technical and business aspects of the MedTech industry.

  • Global Medical Device Podcast · 35m

    #467: Combination Product Compliance: PMOA, 21 CFR Part 4 & QMS Alignment

    Jim Fentress, Director of Regulatory Affairs at Galero (a Santa Group company), explains the regulatory complexities of combination products, focusing on how the Primary Mode of Action (PMOA) dictates FDA oversight. He details the challenges pharmaceutical companies face when integrating device Quality Management Systems (QMSR/ISO 13485) into their existing CGMP frameworks under 21 CFR Part 4. The discussion covers specific friction points like risk management alignment (AAMI TIR105 vs. ICH Q9), labeling classifications, and the critical need for transparent change control protocols between device manufacturers and pharma partners.

  • Global Medical Device Podcast · 36m

    #385: The Trouble with Home-Use Devices, Pt. 1

    Regulatory expert Mike Drues joins host Etienne Nichols to discuss the unique challenges of home-use medical devices, defining them by their intended use environment rather than just location. They analyze the Philips Respironics recall, the largest in industry history, highlighting how foam degradation and failures in post-market surveillance led to a $13 billion settlement. Drues argues that while technical failures might occur in hospitals, the lack of professional oversight in homes exacerbates safety risks and complaint handling difficulties.

  • Being an Engineer · 40m

    S4E49 Derek McKenney | Medical Device Engineering Leadership

    Derek McKenney, Director of Engineering at Puritan Medical Products, discusses the transition from technical engineering to leadership, emphasizing collaboration and overcoming imposter syndrome. He details industry trends in medical device manufacturing, specifically the shift toward compact, at-home testing devices and the need for flexible automation platforms. McKenney highlights significant challenges, including sourcing engineering talent in Maine and managing the rising costs of global regulatory compliance for Class I devices. He concludes by advocating for structured problem-solving skills in young engineers and the importance of team cohesion in achieving complex engineering goals.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.